Lilly To Acquire Verve For One-Time Cardiovascular Treatments
Verve Therapeutics, Inc. (NASDAQ:VERV) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. Eli Lilly and Company will buy Verve Therapeutics, Inc.
Verve Therapeutics Inc. (VERV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 6,904,050 | $31,551,509 | 1.29% | |
| 2. | Casdin Capital Eli Casdin | 3,995,571 | $18,259,759 | 1.49% | |
| 3. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 2,923,418 | $13,360,018 | -23% | 0.08% |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,767,719 | $12,648,476 | 0.08% | |
| 5. | Millennium Management Israel Englander | 2,110,774 | $9,646,237 | -47% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.26 | 76,000 | $475,760.00 | 342,509 | 2024-05-14 | Filing | |
| $10.00 | 1,800,000 | $18,000,000.00 | 1,800,000 | 2023-12-01 | Filing | |
| $12.15 | 10,000 | $121,526.00 | 18,700 | 2022-05-12 | Filing | |
| $21.38 | 4,000 | $85,535.20 | 8,700 | 2022-03-15 | Filing | |
| $32.10 | 4,000 | $128,419.60 | 170,722 | 2021-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.15 | 9,822 | $40,761.30 | 346,686 | 2025-04-02 | Filing | |
| $4.15 | 2,777 | $11,524.55 | 17,420 | 2025-04-02 | Filing | |
| $4.15 | 2,681 | $11,126.15 | 348,828 | 2025-04-02 | Filing | |
| $4.15 | 3,235 | $13,425.25 | 14,226 | 2025-04-02 | Filing | |
| $4.15 | 3,350 | $13,902.50 | 13,280 | 2025-04-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,349,086 | $56,435,323 | 3.58% | |
| 2. | 7,878,236 | $36,003,539 | 0% | |
| 3. | 3,955,099 | $18,074,802 | 0% | |
| 4. | 3,091,189 | $14,126,734 | 0% | |
| 5. | 3,000,000 | $13,710,000 | 1.04% |
News See All
11 Best Genomics Stocks to Buy According to Hedge Funds
Genomics is the study of genes and how they operate.
8 Best Gene-Editing Stocks to Buy
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
7 Best NASDAQ Stocks Under $5
A Yahoo Finance report on September 28 reveals that consumers are beginning to feel the effects of a cooling labor market, according to the latest Consumer Confidence Index, which shows a narrowing gap...
10 Worst ARK Stocks To Buy According To Short Sellers
Investing comes in all sizes and flavors. For the risk averse investors that are looking for steady payouts or long term stability, value and dividend paying stocks are the way to go.
10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
12 Best Short Squeeze Stocks to Buy Now
Plug Power, Inc. (NASDAQ:PLUG), Cinemark Holdings, Inc. (NYSE:CNK), and Allogene Therapeutics, Inc.
Billionaire Hedge Funds
